Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Thoracoabdominal versus transhiatal surgical approaches for adenocarcinoma of the esophagogastric junction-a systematic review and meta-analysis.

Heger P, Blank S, Gooßen K, Nienhüser H, Diener MK, Ulrich A, Mihaljevic AL, Schmidt T.

Langenbecks Arch Surg. 2019 Feb;404(1):103-113. doi: 10.1007/s00423-018-1745-3. Epub 2019 Jan 3.

PMID:
30607534
2.

9 weeks that matter for patients with gastric cancer.

Nienhüser H, Schmidt T.

Lancet Oncol. 2018 Nov;19(11):1418-1419. doi: 10.1016/S1470-2045(18)30752-6. Epub 2018 Oct 21. No abstract available.

PMID:
30355454
3.

Prognostic indicators lose their value with repeated resection of colorectal liver metastases.

Schmidt T, Nienhüser H, Kuna C, Klose J, Strowitzki MJ, Büchler MW, Ulrich A, Schneider M.

Eur J Surg Oncol. 2018 Oct;44(10):1610-1618. doi: 10.1016/j.ejso.2018.07.051. Epub 2018 Jul 31.

PMID:
30115500
4.

Prognostic differences in 8th edition TNM staging of esophagogastric adenocarcinoma after neoadjuvant treatment.

Sisic L, Blank S, Nienhüser H, Dorr S, Haag GM, Jäger D, Bruckner T, Müller-Stich BP, Ott K, Büchler MW, Ulrich A, Schmidt T.

Eur J Surg Oncol. 2018 Oct;44(10):1646-1656. doi: 10.1016/j.ejso.2018.06.030. Epub 2018 Jul 7.

PMID:
30082176
5.

Neoadjuvant Therapy Improves Outcomes in Locally Advanced Signet-Ring-Cell Containing Esophagogastric Adenocarcinomas.

Heger U, Sisic L, Nienhüser H, Blank S, Hinz U, Haag GM, Ott K, Ulrich A, Büchler MW, Schmidt T.

Ann Surg Oncol. 2018 Aug;25(8):2418-2427. doi: 10.1245/s10434-018-6541-3. Epub 2018 May 31.

PMID:
29855828
6.

Short- and Long-Term Oncological Outcome After Rectal Cancer Surgery: a Systematic Review and Meta-Analysis Comparing Open Versus Laparoscopic Rectal Cancer Surgery.

Nienhüser H, Heger P, Schmitz R, Kulu Y, Diener MK, Klose J, Schneider M, Müller-Stich BP, Ulrich A, Büchler MW, Mihaljevic AL, Schmidt T.

J Gastrointest Surg. 2018 Aug;22(8):1418-1433. doi: 10.1007/s11605-018-3738-5. Epub 2018 Mar 27.

PMID:
29589264
7.

Gastric cancer lymph node resection-the more the merrier?

Nienhüser H, Schmidt T.

Transl Gastroenterol Hepatol. 2018 Jan 5;3:1. doi: 10.21037/tgh.2017.12.08. eCollection 2018. No abstract available.

8.

Angiogenesis and Anti-Angiogenic Therapy in Gastric Cancer.

Nienhüser H, Schmidt T.

Int J Mol Sci. 2017 Dec 23;19(1). pii: E43. doi: 10.3390/ijms19010043. Review.

9.

The postoperative part of perioperative chemotherapy fails to provide a survival benefit in completely resected esophagogastric adenocarcinoma.

Sisic L, Blank S, Nienhüser H, Haag GM, Jäger D, Bruckner T, Ott K, Schmidt T, Ulrich A.

Surg Oncol. 2017 Jun 29. pii: S0960-7404(17)30119-6. doi: 10.1016/j.suronc.2017.06.001. [Epub ahead of print]

PMID:
28684226
10.

Inflammatory cytokines are associated with response and prognosis in patients with esophageal cancer.

Blank S, Nienhüser H, Dreikhausen L, Sisic L, Heger U, Ott K, Schmidt T.

Oncotarget. 2017 Jul 18;8(29):47518-47532. doi: 10.18632/oncotarget.17671.

11.

Protein Profiling Gastric Cancer and Neighboring Control Tissues Using High-Content Antibody Microarrays.

Sill M, Schröder C, Shen Y, Marzoq A, Komel R, Hoheisel JD, Nienhüser H, Schmidt T, Kastelic D.

Microarrays (Basel). 2016 Jul 8;5(3). pii: E19. doi: 10.3390/microarrays5030019.

Supplemental Content

Loading ...
Support Center